William LamWilliamLam

Galderma, an EQT portfolio company, in connection with their post-IPO financing.

CVC on the financing in connection with its acquisition of Jagex.

Shelf Drilling Holdings on their refinancing and capital markets issuance.

KSL Capital Partners on the financing in connection with the acquisition of a majority stake in Third Space, the U.K. luxury health and fitness brand.

An EQT-led consortium on financing for the £4.5 billion recommended cash offer of Dechra Pharmaceuticals.

EG Group on a series of complex financing transactions.

TPG on the financing in connection with its acquisition of a majority interest in DOC Generici.

CVC on the financing in connection with its acquisition of RGI.

EQT on the refinancing of the IVC group, together with the establishment of various incremental facilities, having acted for EQT on the original buy-out financing and merger with Evidensia.

EQT on the refinancing of Anticimex.

EQT on the financing in connection with its public-to-private acquisition of Recipharm.

EQT on the financing in connection with its acquisition of thinkproject.

An EQT-led consortium in connection with the financing of its acquisition of Nestlé Skin Health.

EQT on the financing in connection with its acquisition of, and subsequent divestment in, each of: schülke and Rimes.

Equistone on the financing in connection with its acquisition of Moody’s Analytics Knowledge Services and subsequent sale.

EQT on the financing in connection with the acquisition of the SUSE business.

Sivantos, an EQT portfolio company, on the financing in connection with its merger with the Widex group to form WS Audiology.

CVC on the carveout financing for Mooney, having acted for CVC in connection with the original acquisition of the Sisal group.

EQT on the refinancing of the Sitecore business, having acted for EQT on the original buy-out financing.